Trials / Unknown
UnknownNCT05916690
Electrochemotherapy for the Treatment of Vulvar Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Institute of Oncology Ljubljana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Electrochemotherapy is a local treatment modality with effectiveness comparable to other local ablation techniques. With electrochemotherapy 80% objective response can be achieved and is suitable for the treatment of different types of tumors. The method is based on increased drug delivery to cells previously exposed to electroporation. The most commonly used cytotoxic agents are bleomycin and cisplatin. The aim of the proposed clinical trial is to determine the efficacy, feasibility and safety of electrochemotherapy in the treatment of vulvar cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Electrochemotherapy with bleomycin or cisplatin | Combination of drug delivery platform (electroporation) and drug (bleomycin) |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
- First posted
- 2023-06-23
- Last updated
- 2024-01-19
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT05916690. Inclusion in this directory is not an endorsement.